An amphiphilic block copolymer of poly( N ‐vinyl pyrrolidone)‐ b ‐poly(ε‐caprolactone) (PVP‐ b ‐PCL) was synthesized by a combination of cobalt‐mediated radical polymerization (CMRP) and ring‐opening polymerization (ROP). The micellar characteristics of this copolymer were subsequently investigated. PVP ( M n = 11,400, M w / M n = 1.32) was synthesized at 20 °C via CMRP using a molar ratio of [VP] 0 /[V‐70] 0 /[Co] 0 = 150/8/1. The PVP was then reacted with 2,2′‐azobis[2‐methyl‐ N ‐(2‐hydroxyethyl)propionamide] (VA‐086) to modify its cobalt complex chain end to a hydroxyl group. The cobalt (Co) content in the resulting PVP‐OH was 1.2 ppm, indicating that all of the covalent CoC bonds were cleaved and reacted with VA‐086, and that the separated cobalt complexes were successfully removed. The ROP of CL was subsequently carried out using the produced PVP‐OH as a macroinitiator at 110 °C. The GPC trace of PVP‐ b ‐PCL was monomodal without any tailing caused by the residual PVP‐OH, indicating that the initiation efficiency was very high. The critical micelle concentration (CMC) of PVP‐ b ‐PCL ( M n = 18,000, M w / M n = 1.35) was 0.015 mg/mL. The PVP‐ b ‐PCL micelles were spherical in shape with an average diameter of 105 nm. The nanosized PVP‐ b ‐PCL micelles show promise as novel drug carriers in biomedical and pharmaceutical applications.
No takes yet. Share an insight, caveat, or question.
Jeon et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: